Cutler Group LP Paratek Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2018 May 11, 2018	SELL	$12.65 - $18.85 $110,055 - $163,995	-8,700 Reduced 95.6%	400 $0
Q4 2017 Jan 17, 2018	SELL	$17.45 - $25.6 $841,090 - $1.23 Million	-48,200 Reduced 84.12%	9,100 $2,000
Q3 2017 Oct 17, 2017	BUY	$18.9 - $28.2 $1.08 Million - $1.62 Million	57,300	57,300 $274,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.